MyMD Pharmaceuticals (NASDAQ:MYMD) Shares Up 17.9% – Should You Buy?

by · The Cerbat Gem

MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD – Get Free Report) shares traded up 17.9% during mid-day trading on Thursday . The company traded as high as $1.53 and last traded at $1.45. 640,780 shares changed hands during trading, an increase of 378% from the average session volume of 134,123 shares. The stock had previously closed at $1.23.

MyMD Pharmaceuticals Stock Performance

The business’s 50-day moving average price is $1.40 and its 200 day moving average price is $1.64.

About MyMD Pharmaceuticals

(Get Free Report)

MyMD Pharmaceuticals, Inc, a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the aging and age-related and autoimmune diseases, and chronic pain, anxiety, and sleep disorders. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system and its pro-inflammatory cytokines to prevent and treat autoimmune diseases and age-related illnesses, and a Phase 2 clinical trial for sarcopenia, multiple sclerosis, diabetes, inflammatory bowel diseases, and rheumatoid arthritis; inflammation related depression and anxiety; and COVID-19-associated depression.

Featured Articles